Matilda Chan, MD, PhD receives NIH/NEI R21 Award

Congratulations to Matilda Chan, MD, PhD, on her recent award of a National Institutes of Health (NIH)/National Eye Institute (NEI) R21 grant to develop a novel mouse model for Fuchs Dystrophy based on the most common genetic alteration associated with Fuchs (TCF4 trinucleotide repeat).

Fuchs Endothelial Corneal Dystrophy (FECD) is one of the main areas of research in Dr. Chan’s Lab. FECD is a progressive, degenerative disease of the corneal layer of the eye, resulting in corneal swelling and vision loss. FECD is a major cause of vision loss and the leading reason for corneal transplantation in older patients.